Clinical Trials Directory

Trials / Completed

CompletedNCT02899819

MecoExpo Study Protocol

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
1,020 (actual)
Sponsor
Centre Hospitalier Universitaire, Amiens · Academic / Other
Sex
All
Age
2 Days
Healthy volunteers
Not accepted

Summary

The MecoExpo project seeks to evaluate the in utero exposure of newborns in the Picardie region to commonly used pesticides. These pesticides were selected in a pilot study (the Mecopic study) on the basis of their toxicity (effects on foetal development, endocrine perturbation, neurological toxicity and carcinogenicity) and a certain number of indicators of pesticide use and the presence of pesticide in the environment in Picardie. These substances (or their metabolites) will be measured in the each newborn's meconium (the first faeces after birth) and each newborn's mother's hair in the Picardie region during the study period. The mother's exposure will also be assessed using a retrospective questionnaire (filled out within a few days of the delivery). Thus, the MecoExpo project will enable the investigators to: 1. evaluate the relationships between foetal exposure (via the meconium), maternal exposure (via the hair and the questionnaire) and clinical parameters measured at birth (term, length, weight, etc.). 2. map pesticide exposure across the Picardie region. 3. create a meconium bank in Picardie (the first ever meconium bank in France).

Conditions

Interventions

TypeNameDescription
OTHERmeconiumThe meconium will be sampled in the first 2 days of life

Timeline

Start date
2011-02-01
Primary completion
2015-02-01
Completion
2015-02-01
First posted
2016-09-14
Last updated
2025-09-19

Locations

11 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02899819. Inclusion in this directory is not an endorsement.